C105H122Cl4F3N29O7 — CID 160844541
(2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-(3-methyl-2-pyridinyl)piperazine-1-carboxamide;(2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazine-1-carboxamide;(2R)-N-(6-chloro-1H-benzimidazol-2-yl)-4-(3-chloro-2-pyridinyl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-N-(6-methoxy-1H-benzimidazol-2-yl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-2-methyl-N-[5-(2-methylpropyl)-1,3-benzoxazol-2-yl]piperazine-1-carboxamide (PubChem CID 160844541) has the molecular formula C105H122Cl4F3N29O7 and a molecular weight of 2101.13 g/mol. Its IUPAC name is (2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-(3-methyl-2-pyridinyl)piperazine-1-carboxamide;(2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazine-1-carboxamide;(2R)-N-(6-chloro-1H-benzimidazol-2-yl)-4-(3-chloro-2-pyridinyl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-N-(6-methoxy-1H-benzimidazol-2-yl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-2-methyl-N-[5-(2-methylpropyl)-1,3-benzoxazol-2-yl]piperazine-1-carboxamide.
| Compound Name | (2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-(3-methyl-2-pyridinyl)piperazine-1-carboxamide;(2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazine-1-carboxamide;(2R)-N-(6-chloro-1H-benzimidazol-2-yl)-4-(3-chloro-2-pyridinyl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-N-(6-methoxy-1H-benzimidazol-2-yl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-2-methyl-N-[5-(2-methylpropyl)-1,3-benzoxazol-2-yl]piperazine-1-carboxamide |
|---|---|
| PubChem CID | 160844541 |
| Molecular Formula | C105H122Cl4F3N29O7 |
| Molecular Weight | 2101.13 g/mol |
| Exact Mass | 2097.88 |
| IUPAC Name | (2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-(3-methyl-2-pyridinyl)piperazine-1-carboxamide;(2R)-N-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methyl-4-[3-(trifluoromethyl)-2-pyridinyl]piperazine-1-carboxamide;(2R)-N-(6-chloro-1H-benzimidazol-2-yl)-4-(3-chloro-2-pyridinyl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-N-(6-methoxy-1H-benzimidazol-2-yl)-2-methylpiperazine-1-carboxamide;(2R)-4-(3-chloro-2-pyridinyl)-2-methyl-N-[5-(2-methylpropyl)-1,3-benzoxazol-2-yl]piperazine-1-carboxamide |
| SMILES | CC(C)Cc1ccc2oc(NC(=O)N3CCN(c4ncccc4Cl)C[C@H]3C)nc2c1.COc1ccc2nc(NC(=O)N3CCN(c4ncccc4Cl)C[C@H]3C)[nH]c2c1.C[C@@H]1CN(c2ncccc2C(F)(F)F)CCN1C(=O)Nc1nc2ccc(C(C)(C)C)cc2[nH]1.C[C@@H]1CN(c2ncccc2Cl)CCN1C(=O)Nc1nc2ccc(Cl)cc2[nH]1.Cc1cccnc1N1CCN(C(=O)Nc2nc3ccc(C(C)(C)C)cc3[nH]2)[C@H](C)C1 |
| InChI | InChI=1S/C23H27F3N6O.C23H30N6O.C22H26ClN5O2.C19H21ClN6O2.C18H18Cl2N6O/c1-14-13-31(19-16(23(24,25)26)6-5-9-27-19)10-11-32(14)21(33)30-20-28-17-8-7-15(22(2,3)4)12-18(17)29-20;1-15-7-6-10-24-20(15)28-11-12-29(16(2)14-28)22(30)27-21-25-18-9-8-17(23(3,4)5)13-19(18)26-21;1-14(2)11-16-6-7-19-18(12-16)25-21(30-19)26-22(29)28-10-9-27(13-15(28)3)20-17(23)5-4-8-24-20;1-12-11-25(17-14(20)4-3-7-21-17)8-9-26(12)19(27)24-18-22-15-6-5-13(28-2)10-16(15)23-18;1-11-10-25(16-13(20)3-2-6-21-16)7-8-26(11)18(27)24-17-22-14-5-4-12(19)9-15(14)23-17/h5-9,12,14H,10-11,13H2,1-4H3,(H2,28,29,30,33);6-10,13,16H,11-12,14H2,1-5H3,(H2,25,26,27,30);4-8,12,14-15H,9-11,13H2,1-3H3,(H,25,26,29);3-7,10,12H,8-9,11H2,1-2H3,(H2,22,23,24,27);2-6,9,11H,7-8,10H2,1H3,(H2,22,23,24,27)/t14-;16-;15-;12-;11-/m11111/s1 |
| InChIKey | SILXBOLUPWOPDD-RNSVPENASA-N |
| XLogP | 21.51 |
| TPSA | 392.33 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 148 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2101.13 |
| LogP ≤ 5 | 21.51 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 22 |